Xue-Ning Yang

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Liver Metastases

Diffusion Weighted

Small Cell Lung Cancer

Top Venues

Annals of nuclear medicine

Cancer immunology, immunotherapy : CII

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Signal transduction and targeted therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jun-Tao Lin, Xiang-Meng Li, Wen-Zhao Zhong, Qing-Yi Hou, Chun-Ling Liu, Xin-Yue Yu, Kai-Yan Ye, Yi-Lu Cheng, Jia-Yu Du, Yun-Qing Sun, Fu-Gui Zhang, Hong-Hong Yan, Ri-Qiang Liao, Song Dong, Ben-Yuan Jiang, Si-Yang Liu, Yi-Long Wu, Xue-Ning Yang
Impact of preoperative [ 18 F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study. Annals of nuclear medicine (2023)
Jun-Tao Lin, Xiang-Meng Li, Wen-Zhao Zhong, Qing-Yi Hou, Chun-Ling Liu, Xin-Yue Yu, Kai-Yan Ye, Yi-Lu Cheng, Jia-Yu Du, Yun-Qing Sun, Fu-Gui Zhang, Hong-Hong Yan, Ri-Qiang Liao, Song Dong, Ben-Yuan Jiang, Si-Yang Liu, Yi-Long Wu, Xue-Ning Yang
Impact of preoperative [ 18 F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study. Annals of nuclear medicine 38 (3) (2023)
Jun-Tao Lin, Xiang-Meng Li, Wen-Zhao Zhong, Qing-Yi Hou, Chun-Ling Liu, Xin-Yue Yu, Kai-Yan Ye, Yi-Lu Cheng, Jia-Yu Du, Yun-Qing Sun, Fu-Gui Zhang, Hong-Hong Yan, Ri-Qiang Liao, Song Dong, Ben-Yuan Jiang, Si-Yang Liu, Yi-Long Wu, Xue-Ning Yang
Impact of preoperative [ 18 F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study. Annals of nuclear medicine 38 (3) (2023)
Si-Yang Liu, Song Dong, Xue-Ning Yang, Ri-Qiang Liao, Ben-Yuan Jiang, Qun Wang, Xiao-Song Ben, Gui-Bin Qiao, Jun-Tao Lin, Hong-Hong Yan, Li-Xu Yan, Qiang Nie, Hai-Yan Tu, Bin-Chao Wang, Jin-Ji Yang, Qing Zhou, Hong-Rui Li, Ke Liu, Wendy Wu, Si-Yang Maggie Liu, Wen-Zhao Zhong, Yi-Long Wu
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study. Signal transduction and targeted therapy 8 (1) (2023)
Cunte Chen, Si-Yang Maggie Liu, Yuchen Han, Ming Han, Qiuxiang Ou, Hua Bao, Ling Xu, Yi-Kai Zhang, Wen-Zhao Zhong, Wen-Zhao Zhong, Qing Zhou, Xue-Ning Yang, Yang W Shao, Yi-Long Wu, Si-Yang Liu, Yangqiu Li
Poor prognosis of intra-tumoural TRBV6-6 variants in EGFR-mutant NSCLC: Results from the ADJUVANT-CTONG1104 trial. Clinical and translational medicine 12 (4) (2022)
Cunte Chen, Si-Yang Maggie Liu, Yuchen Han, Qiuxiang Ou, Hua Bao, Ling Xu, Yi-Kai Zhang, Wen-Zhao Zhong, Wen-Zhao Zhong, Qing Zhou, Xue-Ning Yang, Yang W Shao, Yi-Long Wu, Si-Yang Liu, Yangqiu Li
Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial. Cancer immunology, immunotherapy : CII (2022)
Wen-Zhao Zhong, Qun Wang, Wei-Min Mao, Song-Tao Xu, Lin Wu, Yu-Cheng Wei, Yong-Yu Liu, Chun Chen, Ying Cheng, Rong Yin, Fan Yang, Sheng-Xiang Ren, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen, Shi-Dong Xu, Lun-Xu Liu, Ping Yu, Bu-Hai Wang, Hai-Tao Ma, Jin-Ji Yang, Hong-Hong Yan, Xue-Ning Yang, Si-Yang Liu, Qing Zhou, Yi-Long Wu
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2020)